Among them, the majority of cases with ER positivity were associated with low tumor budding, and it was statistically significant (p = 0.04), while the other IHC marker HER2/neu was not found to be statistically significant with high tumor budding as most of the HER2neu negative patients were also associated with high tumor budding. Here, ESR1 is linked to neoplasm.